about
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaExpression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patientsAssociations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study.High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer.Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer StudyMolecular and genetic diversity in the metastatic process of melanomaEffects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort studyPrognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant TreatmentExpression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort studyMolecular correlates and prognostic significance of SATB1 expression in colorectal cancer.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancerPrognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancerExpression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma.Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study.Influence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort studyPrognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma.Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohortPrognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer.The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma.The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups.Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
P50
Q27498879-4A96B870-7C45-4E30-89EE-A9A1372A7B74Q33613989-283E8BD7-298D-4C5E-BF65-360BE2A493A0Q33694866-775B7006-8126-4EED-AFDD-5F5AFDD59CF8Q33696650-84D1BFC5-2B75-4B02-B7F2-DFD588C14868Q33740175-0E4909C3-39E6-4FD5-90D2-820192D664F3Q33794854-8070DC82-0A59-4625-8527-4A6E38795C20Q33869036-AB4F4493-3040-421A-A2F6-ABBBF0BAFDCAQ34333522-96DBC5FA-2C94-401B-9D05-FD093D22E970Q35116809-D3AF84CA-D6DA-4C02-B73D-AACEE93C9416Q35166555-C17ACE4F-C2AD-47E4-84E7-CE04D0D5F91DQ35177775-6B130351-435F-443D-8BA2-F19607163C3AQ35213711-ECE10BCE-F26E-43BC-82BA-DE2D59B81562Q35231140-EEA9320E-AFA6-4ABD-8008-57A49E26409DQ35647464-451F7A1A-84D6-4226-AD41-9BE35617F262Q35673791-7DA77E84-A2D3-401C-A16C-B5759C96AAEDQ35987242-62AC2857-B04A-4177-9AFB-DA3F2864D228Q36044748-4AA3DC95-12BE-4C59-BF41-D40FA0A91C36Q36091414-0185F458-E613-4F61-A27D-2A1CEA35CCDFQ36418348-727ECEE6-57CC-43E6-A2A8-A5D6ECF730A8Q36468662-7AC1DB8B-5B58-4BE4-B01D-5D24CDBF6919Q36547753-102BE624-4845-4207-A0E6-AE25EB70540CQ36689001-CF162754-CB1A-46E5-BE74-180A760C25BBQ36762499-F20278EC-9216-4287-93F5-F0698DF4F1F5Q36769318-D6E522BD-3370-4FFC-BF2D-DCD7B230C4D3Q36886612-6A0453D3-571B-4DA6-A0E2-6D3ADAC083E5Q36903912-5C827AD1-740B-4B5E-84D3-0417FA09D284Q37191712-D9A61198-E773-4C46-A019-8A93069DD3ABQ37355802-2704EC52-29BA-40F2-ADA0-19C52A8F60E1Q37418190-8AEFF123-B9D4-49FD-9E02-00974156D9A5Q37525296-EE1D72F1-BFB7-495D-AB81-3A56CA7AACE9Q37610455-1AF08DB0-C08B-4FC0-84AB-455AF6F19AA5Q37697790-BDD1645F-EC82-4BFB-ADA3-AE9E368C5224Q37713640-21CB59B1-C765-421D-A72B-9B82FE9B5882Q40802902-C26CB70F-297F-4D97-BFF2-9F6BB5FE1920Q42359699-0CDD1464-65BE-4726-8C54-DFAE02EE9DA3Q42424860-4E4251F0-026C-49A4-B3CA-F27630661048Q42700830-29C4E302-6413-4612-A5A2-B82DC91FE983Q47273449-DF762B05-D055-4727-8F36-8037283EFB29Q47350408-25EF2379-9FBD-46D2-9B5F-0BA8F84C401DQ47402212-D1FC0CDE-3C8D-4FF4-B7B3-633A2DAF1B03
P50
name
Björn Nodin
@ast
Björn Nodin
@en
Björn Nodin
@nl
type
label
Björn Nodin
@ast
Björn Nodin
@en
Björn Nodin
@nl
prefLabel
Björn Nodin
@ast
Björn Nodin
@en
Björn Nodin
@nl